OGN
Organon & Co
NYSE: OGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$13.34
+0.15% today
Updated 2026-04-29
Market cap
$3.50B
P/E ratio
18.53
P/S ratio
0.56x
EPS (TTM)
$0.72
Dividend yield
2.55%
52W range
$6 – $13
Volume
9.4M
WallStSmart proprietary scores
48
out of 100
Grade: C
Sell
Investment rating
2.7
Growth
F5.0
Quality
C+7.0
Profitability
B+7.0
Valuation
B+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$11.25
-15.67%
12-Month target
$4.88
-63.42%
Intrinsic (DCF)
$59.90
Margin of safety
+87.16%
1 Strong Buy0 Buy3 Hold0 Sell4 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 30.60% — strong efficiency
+ Free cash flow $96.00M — positive
+ 87.16% below intrinsic value
Risks
- Thin margins at 3.01%
- Revenue declining -5.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.17B | $6.26B | $6.40B | $6.22B | $6.22B |
| Net income | $917.00M | $1.02B | $864.00M | $187.00M | $-205.00M |
| EPS | — | — | — | — | $0.72 |
| Free cash flow | $431.00M | $538.00M | $588.00M | $538.00M | $96.00M |
| Profit margin | 14.85% | 16.33% | 13.49% | 3.01% | 3.01% |
Peer comparison
Smart narrative
Organon & Co trades at $13.34. representing a P/E of 18.53x trailing earnings. Our Smart Value Score of 48/100 indicates the stock is fair. TTM revenue stands at $6.22B. with profit margins at 3.01%. Our DCF model estimates intrinsic value at $59.90.
Frequently asked questions
What is Organon & Co's stock price?
Organon & Co (OGN) trades at $13.34.
Is Organon & Co overvalued?
Smart Value Score 48/100 (Grade C, Sell). DCF value $59.90.
What is the price target of Organon & Co (OGN)?
The analyst target price is $11.25, representing -15.7% downside from the current price of $13.34.
What is the intrinsic value of Organon & Co (OGN)?
Based on our DCF model, intrinsic value is $59.90, a +87.2% margin of safety versus $13.34.
What is Organon & Co's revenue?
TTM revenue is $6.22B.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.56x
ROE30.60%
Beta0.64
50D MA$7.59
200D MA$8.41
Shares out0.26B
Float0.26B
Short ratio—
Avg volume9.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—